An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta During Controlled Ovarian Stimulation
Clinical trial NCT06466486 · TERMINATED
Trial details
- NCT number
- NCT06466486
- Sponsor
- Ferring Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-14
- Primary completion
- 2025-12-03
- Enrollment
- 310
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.